OTC Markets OTCPK - Delayed Quote USD

Amplia Therapeutics Limited (INNMF)

0.0450

0.0000

(0.00%)

At close: January 29 at 3:00:00 PM EST

Independent Non-Executive Director of Amplia Therapeutics Robert Peach Buys 25% More Shares

Even if it's not a huge purchase, we think it was good to see that Robert Peach, the Independent Non-Executive Director...

Simply Wall St. last month

INNMF
0.00%
Amplia Therapeutics Stock Down 10.0% But Insiders Still In AU$763k Profit

Insiders who purchased Amplia Therapeutics Limited ( ASX:ATX ) shares in the past 12 months are unlikely to be deeply...

Simply Wall St. 2 months ago

INNMF
0.00%
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER

Amplia Therapeutics Limited (ASX: ATX), ("Amplia" or the "Company"), is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to Amplia's Focal Adhesion Kinase inhibitor, narmafotinib, for the treatment of advanced pancreatic cancer.

PR Newswire 4 months ago

INNMF
0.00%
Allan Moss Buys 40% More Amplia Therapeutics Shares

Investors who take an interest in Amplia Therapeutics Limited ( ASX:ATX ) should definitely note that insider Allan...

Simply Wall St. 8 months ago

INNMF
0.00%

Performance Overview

Return	INNMF	S&P/ASX 200 [XJO]
YTD	+50.00%	+4.44%
1-Year	-10.00%	+10.95%
3-Year	-57.94%	+22.23%